Switching from Gilenya to Lemtrada could trigger MS activity
According to research, switching treatments from Gilenya (fingolimod) to Lemtrada (alemtuzumab) can trigger significant and unexpected disease activity in MS patients...Read more - http://www.ms-uk.org/switching-gilenya- ... ity-070217
Switching from Gilenya to Lemtrada could trigger MS activity
Switching from Gilenya to Lemtrada could trigger MS activity
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1212 Views
-
Last post by frodo
-
- 0 Replies
- 1022 Views
-
Last post by frodo
-
- 0 Replies
- 1078 Views
-
Last post by NHE
-
- 1 Replies
- 1557 Views
-
Last post by ElliotB
-
- 5 Replies
- 14008 Views
-
Last post by gibbledygook